Media-OutReach Newswire Zuellig Pharma and Substipharm Biologics partner to expand access to IMOJEV® vaccine for Japanese encephalitis across Asia
Media-OutReach Newswire Dr. N. Krishna Reddy appointed CEO and Dr. Sten Vermund inducted to ACCESS Health International's Board of Directors